ABSK112 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EGFR Exon20 inhibitor

Filter by location:

Beverly Hills, California1 trial

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer

Precision NextGen Oncology

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.